APA (7th ed.) Citation

Y, Z., Z, Q., H, X., L, L., C, D., Z, H., . . . Y, Z. Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Zhang, Qu Z, Xuan H, Lu L, Ding C, He Z, Gu K, and Zhang Y. Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors. Dove Medical Press.

MLA (9th ed.) Citation

Y, Zhang, et al. Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors. Dove Medical Press.